 | Up a level |
Journal Article
Adler, J., Schmidt, M., Adler, C., Cremer, B., Rudolph, V. and Rosenkranz, S. (2020). Progressive Dyspnea due to neuroendocrine Tumor. Kardiologe, 14 (4). S. 294 - 298. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726
Angermann, C. E. and Rosenkranz, S. (2018). Telemonitoring and pulmonary artery pressure-guided treatment of heart failure. Internist, 59 (10). S. 1041 - 1054. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Barbera, J., Humbert, M., Grueig, E., Jansa, P., Rosenkranz, S., Gall, H., Simonneau, G., Klotsche, J., Chang, M. and Hoeper, M. (2020). Safety of Riociguat for the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Disease: Data from the EXPERT Registry. Am. J. Respir. Crit. Care Med., 201. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Batool, M., Berghausen, E. M., Vantler, M., Zierden, M., Baldus, S., Rosenkranz, S. and Ten Freyhaus, H. (2018). Deficiency of the six-transmembrane protein Stamp2 promotes hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension via cross-talk between macrophages and smooth muscle cells. Eur. Heart J., 39. S. 238 - 239. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Belz, D., Ahrazoglu, M., Moinzadeh, P., Rosenkranz, S. and Hunzelmann, N. (2017). Anaemia and Iron Deficiency in patients with systemic sclerosis. J. Dtsch. Dermatol. Ges., 15. S. 89 - 90. HOBOKEN: WILEY. ISSN 1610-0387
Berghausen, E., Skoruppa, C., Vantler, M., Behringer, A., Joseph, C., Baldus, S. and Rosenkranz, S. (2016). PI3Kdelta mediates growth factor induced PASMC proliferation and hypoxia induced pulmonary hypertension via non-catalytic mechanisms. Eur. Heart J., 37. S. 106 - 108. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Berghausen, E. M., Behringer, A., Vantler, M., Baldus, S. and Rosenkranz, S. (2016). The Orally Available P110a Selective Pi3k Inhibitor Byl719 Reduces Hypoxia-Induced Ph In Mice. Am. J. Respir. Crit. Care Med., 193. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Berghausen, E. M., Feik, L., Zierden, M., Vantler, M. and Rosenkranz, S. (2019). Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension. Herz, 44 (2). S. 130 - 138. MUNICH: URBAN & VOGEL. ISSN 1615-6692
Berghausen, E. M., Janssen, W., Vantler, M., Ten Freyhaus, H., Baldus, S., Schermuly, R. and Rosenkranz, S. (2014). Pharmacological Inhibition Of The Pi 3-Kinase Isoform P110 alpha Prevents Vascular Remodeling And Experimental Ph. Am. J. Respir. Crit. Care Med., 189. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Berman-Rosenzweig, E., Allen, R., Rosenkranz, S., Busse, D., Platt, D. and Ghofrani, H. -A. (2016). Application Of The Criteria For Satisfactory Clinical Response To Riociguat Treatment Of Patients With Pulmonary Arterial Hypertension (patent-1 And Patent-2). Am. J. Respir. Crit. Care Med., 193. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Bokredenghel, S., Mollenhauer, M., Bablok, S., Ruther, T., Proksch, C., Berghausen, E. M., Vantler, M., Rosenkranz, S., Baldus, S., Rudolph, V. and Ten Freyhaus, H. (2018). Stamp2 diminishes structural remodeling and systolic dysfunction in post-ischemic hearts by its anti-inflammatory properties. Eur. Heart J., 39. S. 186 - 187. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Delcroix, M., Staehler, G., Ghofrani, H. A., Gruenig, E., Held, M., Halank, M., Klose, H., Noordegraaf, A. Vonk, Rosenkranz, S., Huscher, D., Pittrow, D. and Hoeper, M. (2018). 2015 ERS/ESC Pulmonary Arterial Hypertension Risk Assessment Model Is also Applicable for Patients with Chronic Thromboembolic Pulmonary Hypertension. Am. J. Respir. Crit. Care Med., 197. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Dumitrescu, D., Gerhardt, F., Viethen, T., Erdmann, E. and Rosenkranz, S. (2011). 70-year-old woman with cardiac hypertrophy and severe pulmonary hypertension: pre- or postcapillary? Dtsch. Med. Wochenschr., 136 (50). S. 2594 - 2599. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Dumitrescu, D., Kovacs, G., Nagel, C., Winkler, J., Halank, M., Gruenig, E., Olschewski, H., Ewert, R. and Rosenkranz, S. (2014). Influence of pulmonary arterial occlusion pressure on the diagnostic accuracy of end-tidal pCO2 measurement during exercise for the detection of scleroderma-associated pulmonary arterial hypertension. Eur. Heart J., 35. S. 73 - 74. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Dumitrescu, D., Kramer, T., Gerhardt, F., Natsina, K., Viethen, T., Baldus, S. and Rosenkranz, S. (2017). Improvement of pulmonary diffusion capacity after intravenous iron substitution in patients with iron deficiency and pulmonary hypertension. Eur. Heart J., 38. S. 748 - 749. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Dumitrescu, D., Kramer, T., Hagmanns, H., Gerhardt, F., Viethen, T., Baldus, S. and Rosenkranz, S. (2018). Intravenous Iron Substitution Improves Pulmonary Diffusion Capacity in Patients with Iron Deficiency and Pulmonary Hypertension. Am. J. Respir. Crit. Care Med., 197. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Dumitrescu, D., Kramer, T., Hagmanns, H., Gerhardt, F., Viethen, T., Baldus, S. and Rosenkranz, S. (2018). Intravenous iron substitution improves pulmonary diffusion capacity in patients with iron deficiency and precapillary pulmonary hypertension. Eur. Heart J., 39. S. 318 - 320. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Dumitrescu, D., Nagel, C., Kovacs, G., Bollmann, T., Halank, M., Winkler, J., Hellmich, M., Grunig, E., Olschewski, H., Ewert, R. and Rosenkranz, S. (2016). Peak oxygen uptake during exercise is able to exclude scleroderma-associated pulmonary arterial hypertension with a high probability. Eur. Heart J., 37. S. 1186 - 1187. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Dumitrescu, D., Viethen, T., Gerhardt, F., Moinzadeh, P., Hunzelmann, N., Baldus, S. and Rosenkranz, S. (2014). Carbon dioxide output kinetics during early recovery from exercise are specifically altered in scleroderma patients with pulmonary arterial hypertension. Eur. Heart J., 35. S. 76 - 77. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Dumitrescu, D., Viethen, T., Gerhardt, F., Moinzadeh, P., Hunzelmann, N. and Rosenkranz, S. (2014). Carbon Dioxide Output Kinetics During Early Recovery From Exercise Are Specifically Altered In Scleroderma Patients With Pulmonary Arterial Hypertension In Different Stages. Am. J. Respir. Crit. Care Med., 189. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Egenlauf, B., Nagel, C., Ewert, R., Lehmkuhl, H., Rosenkranz, S., Benjamin, N., Schwenger, V., Herth, F. and Gruenig, E. (2018). Safety and efficacy of immunoadsorption as an add-on to medical treatment in patients with severe idiopathic pulmonary arterial hypertension (IPAH). Eur. Heart J., 39. S. 320 - 321. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Eichstaedt, C., Sassmannshausen, Z., Gall, H., Seyfarth, H. J., Lerche, M., Halank, M., Xanthouli, P., Harutyunova, S., Egenlauf, B., Milger, K., Rosenkranz, S., Ewert, R., Lankeit, M., Lange, T., Hinderhofer, K. and Gruenig, E. (2020). Genetic findings in patients with different forms of pulmonary hypertension. Pneumologie, 74. S. S22 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Ghofrani, H. A., Distler, O., Gerhardt, F., Gorenflo, M., Gruenig, E., Haefell, W. E., Held, M., Hoeper, M. M., Kaehler, C.-M., Kaemmerer, H., Klose, H., Koellner, V., Kopp, B., Mebus, S., Meyer, A., Miera, O., Pittrow, D., Riemekasten, G., Rosenkranz, S., Schranz, D., Voswinckel, R. and Olschewski, H. (2010). Treatment of pulmonary arterial hypertension (PAH): Recommendations of the Cologne Consensus Conference 2010. Dtsch. Med. Wochenschr., 135. S. S87 - 15. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Held, M. and Rosenkranz, S. (2015). Pulmonary hypertension with lung and left-sided heart diseases. Pneumologe, 12 (5). S. 410 - 417. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1613-6055
Herkenrath, S. D., Treml, M., Kietzmann, I, Anduleit, N., Sofianos, G., Matthes, S., Hagmeyer, L., Rosenkranz, S. and Randerath, W. J. (2020). A pulmonary artery Wedge Pressure of 21 mmHg under Stress separates pre- and postcapillary pulmonary Hypertension under Stress. Pneumologie, 74. S. S125 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Hoeper, M. M., Apitz, C., Gruenig, E., Halank, M., Ewert, R., Kaemmerer, H., Kabitz, H. -J., Kaehler, C., Klose, H., Leuchte, H., Ulrich, S., Olsson, K. M., Distler, O., Rosenkranz, S. and Ghofrani, H. A. (2016). Targeted therapy of pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016. Dtsch. Med. Wochenschr., 141. S. S33 - 11. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Hoeper, M. M., Ghofrani, H. -A., Benza, R. L., Corris, P. A., Gibbs, S., Klinger, J. R., Langleben, D., McLaughlin, V. V., Peacock, A., Rosenkranz, S., Vonk-Noordegraaf, A., White, J., Kleinjung, F., Meier, C. and Simonneau, G. (2017). Rationale And Design Of The Replace Trial: Riociguat Replacing Phosphodiesterase 5 Inhibitor (pde5i) Therapy Evaluated Against Continued Pde5i Therapy In Patients With Pulmonary Arterial Hypertension (pah). Am. J. Respir. Crit. Care Med., 195. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Hoeper, M. M., Opitz, C., Olschewski, H., Ulrich, S., Speich, R., Behr, J., Halank, M., Wilkens, H., Klose, H., Lange, T. J., Gruenig, E., Seeger, W., Ewert, R., Borst, M. M., Welte, T., Rosenkranz, S. and Ghofrani, H. Ardeschir (2014). Use of Imatinib in Patients with Pulmonary Arterial Hypertension Joint Statement of the Group Pulmonary Hypertension of the German Society for Pneumology and the Working Group Pulmonary Hypertension (AG25) of the German Society of Cardiology (DGK). Dtsch. Med. Wochenschr., 139. S. S151 - 4. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Joseph, C., Berghausen, E. M., Vantler, M., Baldus, S. and Rosenkranz, S. (2016). Deficiency of protease-activated receptor 1 and 2 reduce the progression of experimental pulmonary hypertension in mice. Eur. Heart J., 37. S. 832 - 834. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Kiely, D. G., Cottreel, E., Galie, N., Tarcus, J. T., Peacock, A., Rosenkranz, S., Swift, A. J., Tawakol, A., Torbicki, A., Noordegraaf, A. Vonk, Wetherill, G. and Channick, R. (2021). REPAIR: LONG-TERM EFFECTS OF MACITENTAN ON THE RIGHT VENTRICLE (RV) IN PULMONARY ARTERIAL HYPERTENSION (PAH). Thorax, 76. S. A56 - 2. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-3296
Klose, H., Gall, H., Ghofrani, H., Gruenig, E., Humbert, M., Simonneau, G., Halank, M., Langleben, D., Snijder, R. J., Escribano, P., Mielniczuk, L. M., Lange, T., Vachiery, J., Wirtz, H., Helmersen, D. S., Tsangaris, I., Barbera, J. A., Pepke-Zaba, J., Boonstra, A., Rosenkranz, S., Ulrich, S., Mascherbauer, R., Delcroix, M., Jansa, P., Gomez Sanchez, M. A., Klotsche, J., Meier, C., Pittrow, D. and Hoeper, M. M. (2018). Riociguat for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Update from the EXPERT Registry. Am. J. Respir. Crit. Care Med., 197. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Klose, H., Opitz, C., Bremer, H., Ewert, R., Bonderman, D., Rosenkranz, S., Seeger, W., Schmeisser, A., Harbaum, L., Buerke, M., Ghofrani, H. Ardeschir, Borst, M. M., Leuchte, H. H., Lange, T. J., Behr, J., Ulrich, S., Lang, I., Olschewski, H., Gall, H., Kabitz, H. -J., Kleber, F. -X., Held, M., Hoeper, M. M. and Gruenig, E. (2014). Targeted Therapy of pulmonary arterial Hypertension (PAH). Dtsch. Med. Wochenschr., 139. S. S142 - 9. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Kovacs, G., Humbert, M., Herve, P., Avian, A., Galie, N., Lewis, G., Souza, R., Ulrich, S., Noordegraaf, A. Vonk, Andersen, M., Barbera, J. A., Blanco, I, Condliffe, R., D'Alto, M., Egenlauf, B., Ewert, R., Gruenig, E., Heine, A., Herkenrath, S., Hsu, S., Kasperowicz, K., Mak, S., Maron, B., Mccabe, C., Oliveira, R., Rosenkranz, S., Savale, L., Saxer, S., Systrom, D., Tedford, R., Torbicki, A. and Olschewski, H. (2022). Baseline characteristics of patients included into the ERS Clinical Research Collaboration: Pulmonary Hemodynamics during Exercise - Research Network (PEX-NET) registry. Eur. Resp. J., 60. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. ISSN 1399-3003
Kramer, T., Orlova, K., Gerhardt, F., Dumitrescu, D., Ten Freyhaus, H., Baldus, S. and Rosenkranz, S. (2017). Therapeutic effects of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post-and pre-capillary pulmonary hypertension (Cpc-PH). Eur. Heart J., 38. S. 545 - 547. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Kramer, T., Orlova, K., Gerhardt, F., Dumitrescu, D., Ten Freyhaus, H., Baldus, S. and Rosenkranz, S. (2017). Therapeutic potential of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH). Eur. J. Heart Fail., 19. S. 531 - 532. HOBOKEN: WILEY. ISSN 1879-0844
Lang, I., McLaughlin, V., Barbera, J. A., Gomez-Sanchez, M. A., Hoeper, M. M., Jansa, P., Speich, R., Rosenkranz, S., Meier, C., Mueller, K., Nikkho, S., D'Armini, A. M. and Pepke-Zaba, J. (2015). Early Access Study (eas) Of Riociguat In Patients With Chronic Thromboembolic Pulmonary Hypertension (cteph): Baseline Characteristics And Comparison With Registry Data. Am. J. Respir. Crit. Care Med., 191. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Leuchte, H. H., Behr, J., Ewert, R., Ghofrani, H. A., Gruenig, E., Halank, M., Held, M., Klose, H., Rosenkranz, S., Schermuly, R. T., Wilkens, H. and Hoeper, M. M. (2015). Riociguat: Stimulator of Soluble Guanylate-cyclase. Pneumologie, 69 (3). S. 135 - 144. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Leuchte, H. H., Behr, J., Ewert, R., Ghofrani, H. A., Gruenig, E., Halank, M., Held, M., Klose, H., Rosenkranz, S., Schermuly, R. T., Wilkens, H. and Hoeper, M. M. (2015). Riociguat: Stimulator of Soluble Guanylate-cyclase. Pneumologie, 69 (3). S. 135 - 144. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Leuenhagen, S., Burghaus, L., Kukolja, J., Rosenkranz, S., Kabbasch, C., Fink, G. R. and Onur, O. A. (2016). The Therapeutic Dilemma in Treatment of Intracranial Infectious Aneurysm in Patients with Infective Endocarditis: Proposal for a Patient-Centered, Interdisciplinary Treatment Concept. Forschritte Neurol. Psychiatr., 84 (7). S. 411 - 419. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3522
Markl, A., Blank, N., Krysztofiak, K., Berghausen, E., Vantler, M. and Rosenkranz, S. (2015). Insulin receptor substrate 2 (IRS2) overexpression in vascular smooth muscle cells (VSMC) blunts neointima formation in mice. Eur. Heart J., 36. S. 1025 - 1026. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Mauri, V., Reimann, A., Stern, D., Madershahian, N., Scherner, M., Kuhn, E., Rosenkranz, S., Baldus, S., Rudolph, V. and Rudolph, T. K. (2016). Postprocedural pacemaker rate is related to implantation depth and calcium distribution pattern after Sapien 3 implantation. Eur. Heart J., 37. S. 146 - 147. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Noordegraaf, A. Vonk, Channick, R., Cottreel, E., Kiely, D., Martin, N., Moiseeva, O., Peacock, A., Tawakol, A., Torbicki, A., Rosenkranz, S. and Galie, N. (2020). Results from the REPAIR Study Final Analysis: Effects of Macitentan on Right Ventricular (RV) Remodelling in Pulmonary Arterial Hypertension (PAH). J. Heart Lung Transplant., 39 (4). S. S16 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1557-3117
Opitz, C. F., Blindt, R., Blumberg, F., Borst, M. M., Bruch, L., Leuchte, H., Nagel, C., Peters, K., Rosenkranz, S., Schranz, D., Skowasch, D., Lichtblau, M., Tiede, H., Weil, J. and Ewert, R. (2010). Pulmonary hypertension: hemodynamic evaluation - Recommendations of the Cologne Consensus Conference 2010. Dtsch. Med. Wochenschr., 135. S. S78 - 9. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Opitz, C. F., Hoeper, M. M., Huscher, D., Pittrow, D. and Rosenkranz, S. (2015). Treating pulmonary hypertension in patients with heart failure and preserved ejection fraction: safety and efficacy in comparison to IPAH in COMPERA. Eur. Heart J., 36. S. 382 - 383. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Preston, I., Frantz, R., Hemnes, A., Rosenkranz, S., Skaara, H., Pfister, T., Humbert, M. and Howard, L. S. (2018). Rationale and Design of TRACE: A Double-Blind, Placebo-Controlled Phase 4 Study in Pulmonary Arterial Hypertension to Assess the Effect of Selexipag on Physical Activity, Patient-Reported Symptoms and Their Impact, in Daily Life. Am. J. Respir. Crit. Care Med., 197. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Rosenkranz, S. (2017). Cava-Filter not used in Anticoagulation. Kardiologe, 11 (4). S. 248 - 249. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726
Rosenkranz, S. (2014). Cor pulmonale and pulmonary hypertension. Update after the world conference in Nice. Herz, 39 (1). S. 58 - 66. MUNICH: URBAN & VOGEL. ISSN 1615-6692
Rosenkranz, S. (2017). Extended Anticoagulation after Pulmonary Embolism. Kardiologe, 11 (1). S. 2 - 3. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726
Rosenkranz, S. (2020). Pulmonary Hypertension in Left Heart Disease. Kardiologe, 14 (1). S. 2 - 3. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726
Rosenkranz, S. (2017). Temporary Cava-Filter. Kardiologe, 11 (1). S. 2 - 3. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726
Rosenkranz, S. (2017). Updated Nice-Classification of pulmonary Hypertension. Kardiologe, 11 (1). S. 3 - 4. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726
Rosenkranz, S. (2017). Venous Thromboembolism: Screening for malignant Diseases? Kardiologe, 11 (1). S. 3 - 4. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726
Rosenkranz, S. (2014). We heal wounds. Dtsch. Med. Wochenschr., 139 (33). S. 1645 - 1647. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Rosenkranz, S., Baldus, S., Grunig, E., Klose, H., Opitz, C. and Hoeper, M. M. (2016). Comment on the 2015 ESC/ERS guidelines on the diagnosis and treatment of pulmonary hypertension. Kardiologe, 10 (4). S. 211 - 222. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726
Rosenkranz, S., Behr, J., Ewert, R., Ghofrani, H. A., Gruenig, E., Halank, M., Hoeper, M. M., Leuchte, H. H., Olschewski, H., Schmeisser, A., Speich, R., Wilkens, H. and Opitz, C. F. (2011). Right heart catheterization in pulmonary hypertension. Dtsch. Med. Wochenschr., 136 (50). S. 2601 - 2617. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Rosenkranz, S., Bonderman, D., Buerke, M., Felgendreher, R., ten Freyhaus, H., Gruenig, E., de Haan, F., Hammerstingl, C., Harreuter, A., Hohenforst-Schmidt, W., Kindermann, I., Kindermann, M., Kleber, F. -X., Kuckeland, M., Kuebler, W. M., Mertens, D., Mitrovic, V., Opitz, C., Schmeisser, A., Schulz, U., Speich, R., Zeh, W. and Weil, J. (2010). Pulmonary hypertension due to left heart disease: Recommendations of the Cologne Consensus Conference 2010. Dtsch. Med. Wochenschr., 135. S. S102 - 13. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Rosenkranz, S., Channick, R., Chin, K., Jenner, B., Gaine, S., Galie, N., Ghofrani, H. A., Hoeper, M. M., McLaughlin, V, Preiss, R., Rubin, L., Simonneau, G., Sitbon, O., Tapson, V and Lang, I (2020). Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities. Pneumologie, 74. S. S62 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Rosenkranz, S., Ghofrani, H. A., Gruenig, E. and Hoeper, M. M. (2010). Cologne consenus conference on pulmonary hypertension 2010. Dtsch. Med. Wochenschr., 135. S. S64 - 3. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Rosenkranz, S., Ghofrani, H. A., Gruenig, E., Klose, H., Olschewski, H. and Hoeper, M. M. (2016). Cologne Consensus Conference on Pulmonary Hypertension 2016. Dtsch. Med. Wochenschr., 141. S. S1 - 4. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Rosenkranz, S., Kramer, T., Gerhardt, F., Opitz, C., Olsson, K. M. and Hoeper, M. M. (2019). Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches. Herz, 44 (6). S. 483 - 491. MUNICH: URBAN & VOGEL. ISSN 1615-6692
Rosenkranz, S., Lang, I. M., Blindt, R., Bonderman, D., Bruch, L., Diller, G. P., Felgendreher, R., Gerges, C., Hohenforst-Schmidt, W., Holt, S., Jung, C., Kindermann, I., Kramer, T., Kuebler, W. M., Mitrovic, V., Riedel, A., Rieth, A., Schmeisser, A., Wachter, R., Weil, J. and Opitz, C. (2016). Pulmonary hypertension associated with left heart disease: recommendations of the Cologne Consensus Conference 2016. Dtsch. Med. Wochenschr., 141. S. S48 - 12. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413
Sulica, R., Frey, R., Van Der Mey, D., Platt, D. M., Saleh, S., Steiper, M. and Rosenkranz, S. (2017). The Rationale For A Washout Period When Switching Patients From Pde5i To Riociguat. Am. J. Respir. Crit. Care Med., 195. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Ten Freyhaus, H., Batool, M., Berghausen, E. M., Joseph, C., Zierden, M., Vantler, M., Baldus, S. and Rosenkranz, S. (2017). The six-transmembrane protein Stamp2 protects from pulmonary vascular remodeling and pulmonary hypertension in mice. Eur. Heart J., 38. S. 1340 - 1341. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Ten Freyhaus, H., Batool, M., Berghausen, E. M., Zierden, M., Vantler, M., Baldus, S. and Rosenkranz, S. (2016). The six-transmembrane protein Stamp2 protects from experimental pulmonary hypertension. Eur. Heart J., 37. S. 908 - 909. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Ten Freyhaus, H., Berghausen, E. M., Janssen, W., Leuchs, M., Zierden, M., Vantler, M., Baldus, S., Schermuly, R. T., Tallquist, M. D. and Rosenkranz, S. (2014). Critical role of PDGF-induced PI3 kinase and PLCg signaling in human and experimental pulmonary hypertension. Eur. Heart J., 35. S. 198 - 199. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Ten Freyhaus, H., Dumitrescu, D., Schnorbach, S., Kappert, K., Viethen, T., Hellmich, M., Baldus, S., Hunuzelmann, N. and Rosenkranz, S. (2015). CT-proET1 predicts survival in scleroderma-associated pulmonary hypertension. Eur. Heart J., 36. S. 627 - 628. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Ten Freyhaus, H., Mollenhauer, M., Bokredenghel, S., Bablok, S., Ruther, T., Proksch, C., Berghausen, E. M., Vantler, M., Rosenkranz, S., Baldus, S. and Rudolph, V. (2017). Deficiency of the six-transmembrane protein Stamp2 promotes structural remodeling and systolic dysfunction in left ventricular myocardial ischemia-reperfusion injury. Eur. Heart J., 38. S. 1138 - 1139. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Tichelbaecker, T., Dumitrescu, D., Gerhardt, F., Stern, D., Wissmueller, M., Adam, M., Schmidt, T., Frerker, C., Pfister, R., Halbach, M., Baldus, S. and Rosenkranz, S. (2019). Pulmonary hypertension and valvular heart disease. Herz, 44 (6). S. 491 - 502. MUNICH: URBAN & VOGEL. ISSN 1615-6692
Vantler, M., Alfitian, J., Gerhardt, M., Berghausen, E. M., Zierden, M., Baldus, S., Sandner, P. and Rosenkranz, S. (2018). SGC-stimulation via BAY 41-2272 exerts antiatherogenic effects in LDLR- and ApoE-deficient mice. Eur. Heart J., 39. S. 803 - 804. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Vantler, M., Jesus, J., Leppaenen, O., Chen, X., Gerhardt, M., Berghausen, E., Zierden, M., Baldus, S., Zhao, J. J. and Rosenkranz, S. (2015). PI3Kalpha induced SMC migration and cell cycle progression is crucial for neointima formation following vascular injury. Eur. Heart J., 36. S. 375 - 376. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Zedler, D., Richter, J. M., Berliner, D., Douschan, P., Gall, H., Ghofrani, A. H., Kimmig, L., Kremer, N., Olsson, M. K., da Rocha, Brito B., Rosenkranz, S., Seeger, W., Yogeswaran, A., Rako, A. Z. and Tello, K. (2022). Clinical Relevance of right atrial Function in Patients with pulmonary arterial Hypertension. Pneumologie, 76. S. S57 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Zierden, M., Millarg, C., Berghausen, E. M., Baldus, S., Vantler, M. and Rosenkranz, S. (2018). PI3-kinase delta protects against atherosclerosis progression by controlling regulatory T-cell homeostasis and function. Eur. Heart J., 39. S. 254 - 255. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Zierden, M., Millarg, C., Herbers, C., Vantler, M., Berghausen, E., Baldus, S. and Rosenkranz, S. (2014). Hematopoietic PI3-kinase delta-deficiency aggravates lesional macrophage infiltration and atherosclerosis in LDLR-/- mice. Eur. Heart J., 35. S. 614 - 615. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Zierden, M., Millarg, C., Vantler, M., Berghausen, E. M., Baldus, S. and Rosenkranz, S. (2017). Hematopoietic PI3-kinase delta-deficiency aggravates atherosclerosis by impairment of regulatory T cells. Eur. Heart J., 38. S. 1071 - 1072. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Zierden, M., Millarg, C., Vantler, M., Berghausen, E. M., Baldus, S. and Rosenkranz, S. (2016). Hematopoietic PI3-kinase delta-deficiency causes B-1 cell depletion, impaired regulatory T-cell function and aggravated atherosclerosis in LDLR-/- mice. Eur. Heart J., 37. S. 1008 - 1010. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
ten Freyhaus, H., Vogel, D., Lehmann, C., Kuemmerle, T., Wyen, C., Faetkenheuer, G. and Rosenkranz, S. (2014). Echocardiographic screening for pulmonary arterial hypertension in HIV-positive patients. Infection, 42 (4). S. 737 - 742. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973